The presence of protective SARS-CoV-2-specific memory B and T (CD4+ and CD8+) cells were observed 3 months after mildly symptomatic COVID-19 [9], while specific memory T cells were present after mild or severe COVID-19 [10]. The gene discussed is CD8A; the disease is COVID-19.